Quantitative Secretome Analysis Reveals Clinical Values of Carbonic Anhydrase II in Hepatocellular Carcinoma

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Wang, 2014, The global burden of liver disease: the major impact of China, Hepatology, 60, 2099, 10.1002/hep.27406 Zhou, 2001, Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma, Cancer, 91, 1479, 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0 Ng, 2009, Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma, HPB (Oxford), 11, 311, 10.1111/j.1477-2574.2009.00044.x Lee, 2011, Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discovery, J Proteome Res, 10, 5070, 10.1021/pr2005204 Iizuka, 2003, Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection, Lancet, 361, 923, 10.1016/S0140-6736(03)12775-4 Sterling, 2012, Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C, Am J Gastroenterol, 107, 64, 10.1038/ajg.2011.312 Liu, 2010, Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases, J Surg Oncol, 102, 249, 10.1002/jso.21624 El-Bahrawy, 2010, Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract, Eur J Cancer, 46, 1317, 10.1016/j.ejca.2010.01.028 Qiao, 2012, Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach, Int J Mol Med, 29, 832 Song, 2011, Mitochondrial peroxiredoxin III is a potential target for cancer therapy, Int J Mol Sci, 12, 7163, 10.3390/ijms12107163 Xing, 2015, Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics, J Proteomics, 128, 262, 10.1016/j.jprot.2015.08.007 Feng, 2005, Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis, Proteomics, 5, 4581, 10.1002/pmic.200401309 Veenstra, 2005, Biomarkers: mining the biofluid proteome, Mol Cell Proteomics, 4, 409, 10.1074/mcp.M500006-MCP200 Anderson, 2002, The human plasma proteome: history, character, and diagnostic prospects, Mol Cell Proteomics, 1, 845, 10.1074/mcp.R200007-MCP200 Hanash, 2008, Mining the plasma proteome for cancer biomarkers, Nature, 452, 571, 10.1038/nature06916 Paltridge, 2013, The secretome in cancer progression, Biochim Biophys Acta, 1834, 2233, 10.1016/j.bbapap.2013.03.014 Slany, 2013, Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling, Electrophoresis, 34, 3315, 10.1002/elps.201300326 Yu, 2013, An iTRAQ based quantitative proteomic strategy to explore novel secreted proteins in metastatic hepatocellular carcinoma cell lines, Analyst, 138, 4505, 10.1039/c3an00517h Cao, 2009, Nanozeolite-driven approach for enrichment of secretory proteins in human hepatocellular carcinoma cells, Proteomics, 9, 4881, 10.1002/pmic.200800877 Xing, 2016, The application of proteomics in different aspects of hepatocellular carcinoma research, J Proteomics, 145, 70, 10.1016/j.jprot.2016.03.050 Yang, 2013, Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma, Sci China Life Sci, 56, 638, 10.1007/s11427-013-4497-x Chang, 2001, Mammalian MAP kinase signalling cascades, Nature, 410, 37, 10.1038/35065000 Gaesser, 2016, Intracellular signaling pathway regulation of myelination and remyelination in the CNS, Exp Neurol, 283, 501, 10.1016/j.expneurol.2016.03.008 Gherardi, 2012, Targeting MET in cancer: rationale and progress, Nat Rev Cancer, 12, 89, 10.1038/nrc3205 Veillette, 2013, Regulation of the PI3-K/Akt survival pathway in the rat endometrium, Biol Reprod, 88, 1, 10.1095/biolreprod.112.107136 Solit, 2003, Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol, Cancer Res, 63, 2139 Noor, 2018, A surface proton antenna in carbonic anhydrase II supports lactate transport in cancer cells, Elife, 7, e35176, 10.7554/eLife.35176 Chiang, 2002, The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer, Cancer Lett, 188, 199, 10.1016/S0304-3835(02)00078-2 Mallory, 2005, A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells, Mol Pharmacol, 68, 1747, 10.1124/mol.105.016519 Haapasalo, 2007, Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy, Neuro Oncol, 9, 308, 10.1215/15228517-2007-001 Zhou, 2015, Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors, Am J Respir Cell Mol Biol, 52, 183, 10.1165/rcmb.2014-0054OC Parks, 2017, Targeting pH regulating proteins for cancer therapy-Progress and limitations, Semin Cancer Biol, 43, 66, 10.1016/j.semcancer.2017.01.007 Viikila, 2016, Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas, World J Gastroenterol, 22, 8168, 10.3748/wjg.v22.i36.8168 Zhou, 2013, CA II, a potential biomarker by proteomic analysis, exerts significant inhibitory effect on the growth of colorectal cancer cells, Int J Oncol, 43, 611, 10.3892/ijo.2013.1972 Liu, 2013, Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors, World J Gastroenterol, 19, 2473, 10.3748/wjg.v19.i16.2473 Takahashi, 2003, Molecular subclassification of kidney tumors and the discovery of new diagnostic markers, Oncogene, 22, 6810, 10.1038/sj.onc.1206869 Hynninen, 2012, Carbonic anhydrase isozymes II, IX, and XII in uterine tumors, APMIS, 120, 117, 10.1111/j.1600-0463.2011.02820.x Liu, 2012, Expression of carbonic anhydrases I/II and the correlation to clinical aspects of oral squamous cell carcinoma analyzed using tissue microarray, J Oral Pathol Med, 41, 533, 10.1111/j.1600-0714.2012.01135.x Parkkila, 2000, Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro, Proc Natl Acad Sci U S A, 97, 2220, 10.1073/pnas.040554897 Liu, 2019, The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection, Cancer Manag Res, 11, 2935, 10.2147/CMAR.S190561 Zhang, 2018, Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma, Carcinogenesis, 39, 562, 10.1093/carcin/bgx148 Dunn, 2011, Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry, Nat Protoc, 6, 1060, 10.1038/nprot.2011.335 Liu, 2018, Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials, Oncol Lett, 16, 335 Song, 2010, Reversed-phase-reversed-phase liquid chromatography approach with high orthogonality for multidimensional separation of phosphopeptides, Anal Chem, 82, 53, 10.1021/ac9023044 Huang, 2014, Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection, Proteome Sci, 22, 1, 10.1186/1477-5956-12-1 Ma, 2019, iProX: an integrated proteome resource, Nucleic Acids Res, 47, D1211, 10.1093/nar/gky869